Composition
- Active ingredients
- CEFUROXIME AXETIL EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFUROXIME AXETIL EQ 250MG BASE/5ML · For suspensionNDA050672-002 · Discontinued
- CEFUROXIME AXETIL EQ 125MG BASE/5ML · For suspensionNDA050672-001 · Discontinued
- CEFUROXIME AXETIL EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA050605-003 · Discontinued
- CEFUROXIME AXETIL EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- CEFUROXIME AXETIL EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA050605-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050605.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ceftin
- Active substance
- cefuroxime axetil
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 28 Dec 1987
- Application
- NDA050605-001